Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
7.89
+0.14 (1.81%)
Feb 4, 2026, 3:04 PM CST
-39.63%
Market Cap3.27B -51.5%
Revenue (ttm)216.15M +19.7%
Net Income-42.99M
EPS-0.10
Shares Out414.69M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,820,100
Average Volume9,748,518
Open7.39
Previous Close7.75
Day's Range7.39 - 7.92
52-Week Range6.32 - 18.93
Beta0.44
RSI58.81
Earnings DateApr 29, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

In 2024, SHE:002693's revenue was 174.21 million, a decrease of -26.16% compared to the previous year's 235.93 million. Losses were -78.30 million, 54.3% more than in 2023.

Financial Statements